Webb*The adveva® patient support program and some Rebif® self-injection devices are not available in all countries. Please check local prescribing information **For CRM … WebbOcrelizumab, sold under the brand name Ocrevus, is a medication used for the treatment of multiple sclerosis (MS). It is a humanized anti- CD20 monoclonal antibody. [5] It targets CD20 marker on B lymphocytes and hence is an immunosuppressive drug. [7] Ocrelizumab binds to an epitope that overlaps with the epitope to which rituximab binds. [7]

*Sections or subsections omitted from the full prescribing - Rebif

WebbRebif® is approved for use during pregnancy and lactation **1 LACTATION Rebif® can be used during lactation as opposed to most other disease-modifying therapies 1,10-20 … WebbSmPC Download Center MAVENCLAD (cladribine tablets) is indicated in patients with highly active relapsing MS and is the only DMD that can deliver and sustain 4 years of … asepa hdri

Rebif European Medicines Agency

WebbRebif (interferon beta-1a) was approved in Europe on 4 May 1998. The currently approved indication is for the treatment of relapsing forms of MS. The recommended posology of … WebbRebif ist als Injektionslösung in Fertigspritzen mit einer Festnadel zur Selbstanwendung verfügbar. Die Fertigspritze ist gebrauchsfertig. Rebif kann auch mit einem geeigneten Autoinjektor verabreicht werden. Drei Dosierungen sind verfügbar: 8.8 Mikrogramm, 22 Mikrogramm und 44 Mikrogramm. Dosierung Webb‡If clinically needed, the use of Rebif® may be considered during pregnancy. Experience with exposure during the second and third trimester is very limited 1. sc, subcutaneous; … asepama